ORPRO THERAPEUTICS, INC.

Profile

Company Names

ORPRO THERAPEUTICS, INC.

Addresses

C/O LATHAM + WATKINS LLP, 12636 HIGH BLUFF DR., SUITE 400, SAN DIEGO, CA 92130

Phone Numbers

(858) 353-3630

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$2,337,994.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2013-12-11 
$2,337,994.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CAM 
L. 
GARNER 
EXECUTIVE OFFICER, DIRECTOR
ZOGENIX INC   |  MERITAGE PHARMA INC   |  ELEVATION PHARMACEUTICALS INC   |  NEURELIS, INC.   |  EVOKE PHARMA INC   |  KALYRA PHARMACEUTICALS, INC.   |  ORPRO THERAPEUTICS, INC.   |  TOKALAS, INC.   |  ALASTIN SKINCARE, INC.   |  ZAVANTE THERAPEUTICS, INC.   |  ADIGICA HEALTH, INC.   |  ONCTERNAL THERAPEUTICS, INC.
PETER 
B. 
HEIFETZ, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
ORPRO THERAPEUTICS, INC.
MARY 
JACQUELINE 
JOHNSON 
DIRECTOR
ORPRO THERAPEUTICS, INC.   |  SYDNEXIS, INC.
JEFFREY 
W. 
RASER 
DIRECTOR
SOMAXON PHARMACEUTICALS, INC.   |  ORPRO THERAPEUTICS, INC.
JAMES 
 
WEIL 
DIRECTOR
NERVEDA LLC   |  ORPRO THERAPEUTICS, INC.   |  WASTE REPURPOSING INTERNATIONAL, INC.   |  WORKLYN PARTNERS LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-02-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-11 
2013-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#